The ASX is chock-full of great companies. There are companies not only dominating the domestic landscape, but the global landscape too. And they’re always working towards growth. I’d go so far to say there’s not a single company on the ASX that’s just going through the motions.
Explore Small Cap Opportunities on the ASX
Of the approximately 2,000 companies listed on ASX, just over 1,400 – or 70% – are below $200 million in market capitalisation. 867 of these 1,400 stocks have a market capitalisation below $50 million.
But while small caps comprise the majority of the ASX, it is the bigger names that get most of the market’s attention. Names like BHP Billiton, Telstra, Commonwealth Bank, Woolworths, Wesfarmers – the list is long.
These big companies are popular with most investors. And, in a good year, they can see strong gains, sometimes between 20% or 30%.
But what the average investor doesn’t realise is that some of the most exciting, interesting, and world-leading stocks with potential for large returns are frequently found more often in the small cap sector
Compumedics Share Price Up Big on FDA Approval (ASX: CMP)
At time of writing, the share price of Compumedics Ltd [ASX:CMP] is up a significant 25.47% on important FDA approval. It’s been a remarkable 12 months for the stock, with the Compumedics share price rising a total of 154% during this period…